| Serial Number | 87875065 |
| Word Mark | CRINETICS PHARMACEUTICALS |
| Filing Date | Thursday, April 12, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, July 19, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 18, 2018 |
| Goods and Services | Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 21, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, May 12, 2021 |
| First Use In Commerce Date | Wednesday, May 12, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 21, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, May 12, 2021 |
| First Use In Commerce Date | Wednesday, May 12, 2021 |
| Party Name | Crinetics Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Crinetics Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Tuesday, July 19, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, July 19, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, January 5, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 5, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 5, 2022 | SU - NON-FINAL ACTION - WRITTEN |
| Tuesday, November 30, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, October 29, 2021 | USE AMENDMENT FILED |
| Friday, October 29, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, May 8, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 7, 2021 | SOU EXTENSION 5 GRANTED |
| Thursday, April 29, 2021 | SOU EXTENSION 5 FILED |
| Friday, May 7, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, April 29, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 30, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 28, 2020 | SOU EXTENSION 4 GRANTED |
| Wednesday, October 28, 2020 | SOU EXTENSION 4 FILED |
| Wednesday, October 28, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 28, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 24, 2020 | SOU EXTENSION 3 GRANTED |
| Friday, April 24, 2020 | SOU EXTENSION 3 FILED |
| Friday, April 24, 2020 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 23, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 21, 2019 | SOU EXTENSION 2 GRANTED |
| Monday, October 21, 2019 | SOU EXTENSION 2 FILED |
| Monday, October 21, 2019 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 19, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 17, 2019 | SOU EXTENSION 1 GRANTED |
| Wednesday, April 17, 2019 | SOU EXTENSION 1 FILED |
| Wednesday, April 17, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 17, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 17, 2019 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, November 13, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 18, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 18, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 29, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 16, 2018 | ASSIGNED TO LIE |
| Monday, August 6, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 6, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 6, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 6, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 6, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 31, 2018 | ASSIGNED TO EXAMINER |
| Saturday, April 21, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 16, 2018 | NEW APPLICATION ENTERED |